TrialClinical cancer research : an official journal of the American Association for Cancer Research2026
Osimertinib plus Gefitinib in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer and EGFR (C797X) Mutation Following First-Line Osimertinib: ORCHARD.
Sarah B Goldberg et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.